The Hepatitis B e Antibody (anti-HBe) test is an essential diagnostic tool for assessing the infection status of individuals with hepatitis B virus (HBV). This test detects the presence of anti-HBe antibodies, which typically emerge during the recovery phase of acute hepatitis B, indicating reduced viral replication and lower infectivity risk. The primary purpose of the anti-HBe test is to evaluate the stage and prognosis of HBV infection, helping to determine whether the virus is actively replicating or has entered a latent phase. A positive anti-HBe result suggests a transition to a less active infection phase, while its absence, especially alongside the presence of Hepatitis B e Antigen (HBeAg), indicates active viral replication. The test requires a serum or plasma specimen and is performed using competitive chemiluminescence immunoassay (CLIA) or electrochemiluminescence immunoassay (ECLIA). It is crucial for monitoring the serologic response in chronically HBV-infected patients undergoing antiviral therapy, aiding in effective infection management.
The Hepatitis B e Antibody (anti-HBe) test is an essential diagnostic tool for assessing the infection status of individuals with hepatitis B virus (HBV). This test detects the presence of anti-HBe antibodies, which typically emerge during the recovery phase of acute hepatitis B, indicating reduced viral replication and lower infectivity risk. The primary purpose of the anti-HBe test is to evaluate the stage and prognosis of HBV infection, helping to determine whether the virus is actively replicating or has entered a latent phase. A positive anti-HBe result suggests a transition to a less active infection phase, while its absence, especially alongside the presence of Hepatitis B e Antigen (HBeAg), indicates active viral replication. The test requires a serum or plasma specimen and is performed using competitive chemiluminescence immunoassay (CLIA) or electrochemiluminescence immunoassay (ECLIA). It is crucial for monitoring the serologic response in chronically HBV-infected patients undergoing antiviral therapy, aiding in effective infection management.
The lowest price from the last 30 days: £108
Awaiting result:
12 hours
Collect material:
Blood
Prepare:
The Hepatitis B e Antibody (anti-HBe) test is vital for assessing hepatitis B infection status. It helps determine the infection stage and prognosis by indicating viral replication levels. Key points include:
- Presence of Anti-HBe: Suggests reduced viral replication and lower infectivity, marking a transition to a less active infection phase.
- Absence of Anti-HBe: Indicates active viral replication and high infectivity, especially if HBeAg is present.
- Clinical Implications: Anti-HBe presence signals recovery and long-term immunity but requires ongoing monitoring in chronic carriers.
Specimen collection involves serum or plasma, with specific storage and rejection criteria.
The Hepatitis B e Antibody (anti-HBe) test is vital for assessing hepatitis B infection status. It helps determine if the virus is actively replicating or in a latent phase. Key points include:
- Presence of Anti-HBe: Indicates reduced viral replication and lower infectivity. However, HBV DNA may still be present.
- Absence of Anti-HBe: Suggests active viral replication and high infectivity.
- Specimen Requirements: Requires 0.5 mL serum/plasma.
- Storage: Room temperature (7 days), refrigerated (14 days), frozen (14 days).
- Methodology: Uses chemiluminescence immunoassay.
This test is crucial for monitoring chronic HBV infection and treatment efficacy.
Understanding test results for the Hepatitis B e Antibody (anti-HBe) test is vital for managing HBV infection. This test helps determine the infection stage and prognosis by assessing viral replication activity.
- Presence of Anti-HBe:
- Indicates reduced viral replication and lower infectivity.
- Suggests transition to a less active infection phase.
- Absence of Anti-HBe:
- Suggests active viral replication and high infectivity.
- Clinical Implications:
- Signals recovery from acute hepatitis B.
- Requires ongoing monitoring in chronic carriers.
This test aids in evaluating treatment efficacy and infection management.
The lowest price from the last 30 days: £108
What is GetLabTest.com?
How do I get started with GetLabTest.com?
What diseases can GetLabTest.com detect?
How do I prepare for testing with GetLabTest.com?
Can I speak with a doctor about my results?
Is testing with GetLabTest.com covered by insurance?
How long does it take to receive the test results?
Can I access my test results online?
Is my personal information kept confidential?
What if I have questions or concerns about my test results?